Innovations in Liquid Biopsy Techniques for Cancer Management 2017: Leading the Transformation of Cancer Profiling & Personalized Treatment Strategies - Research and Markets

DUBLIN--()--The "Innovations in Liquid Biopsy Techniques for Cancer Management" report has been added to Research and Markets' offering.

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs), derived from bio-fluids such as blood and urine, for molecular analysis across research and healthcare settings.

This study also evaluates the technology, clinical, patent, and application landscapes prevalent across liquid biopsy settings, while providing valuable insights across its global technological impact and future perspectives.

Key Topics Covered:

1.0 Executive Summary

2.0 Technology Snapshot and Overview

3.0 Technologies Analyzing ctDNA

4.0 Technologies Enabling CTC Detection

5.0 Technologies for Assessment of Extracellular Vesicles

6.0 Impact Analysis and Future Perspectives

7.0 Growth Opportunities and Companies to Action

8.0 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/kjk8cv/innovations_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics